1. Home
  2. OBK vs ABCL Comparison

OBK vs ABCL Comparison

Compare OBK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Origin Bancorp Inc.

OBK

Origin Bancorp Inc.

HOLD

Current Price

$43.97

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.04

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBK
ABCL
Founded
1912
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
OBK
ABCL
Price
$43.97
$3.04
Analyst Decision
Strong Buy
Buy
Analyst Count
7
5
Target Price
$44.29
$7.75
AVG Volume (30 Days)
234.5K
3.8M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
1.36%
N/A
EPS Growth
N/A
N/A
EPS
1.46
N/A
Revenue
N/A
$28,833,000.00
Revenue This Year
$25.48
$26.18
Revenue Next Year
$5.79
$13.51
P/E Ratio
$30.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.80
$1.89
52 Week High
$46.02
$6.52

Technical Indicators

Market Signals
Indicator
OBK
ABCL
Relative Strength Index (RSI) 56.03 40.69
Support Level $42.75 $3.06
Resistance Level $45.05 $3.24
Average True Range (ATR) 1.24 0.21
MACD -0.29 -0.01
Stochastic Oscillator 20.49 39.68

Price Performance

Historical Comparison
OBK
ABCL

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: